Why the study?
Does aspirin therapy reduce vein-graft occlusion and ischemic complications in at-risk medical patients?
Population
at-risk medical patients and patients at risk for vein-graft occlusion
Comparison
aspirin therapy vs no aspirin therapy
Design
Editorial
Loading...
The author highlights the ethical dilemma of conducting randomized trials that withhold aspirin in at-risk patients, given its established benefits, safety, and low cost.
Does aspirin therapy reduce vein-graft occlusion and ischemic complications in at-risk medical patients?
The author highlights the ethical dilemma of conducting randomized trials that withhold aspirin in at-risk patients, given its established benefits, safety, and low cost.
A 2003 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: